Product Information
PAROXETINE HCL 40 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1000 per EA under NDC 16714018403. Its NADAC has been published 218 times since Jun 1, 2022.
FDA first approved this application on Jul 25, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
NorthStar Rx LLCNDC
16714018403
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
PAROXETINE HYDROCHLORIDE HEMIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA078406FDA Approved
7/25/2007
TE Code
AB
On Market Since
7/25/2007
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE HCL 40 MG TABLET has been published 218 times since Jun 1, 2022, and over the history we have for it it has declined 26.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1000 per EA |
|---|---|
| All-time high | $0.1459 (Aug 10, 2022) |
| All-time low | $0.0864 (Nov 20, 2024) |
| 52-week high | $0.1131 |
| 52-week low | $0.1000 |
| Median price | $0.1134 |
| Average price | $0.1171 |
| Largest weekly change | +30.0% (Aug 21, 2024) |
| Weeks tracked | 218 |
| Tracking since | Jun 1, 2022 |
1W
N/A
1M
0.0%
3M
-8.4%
6M
-8.1%
1Y
-8.3%
3Y
-6.8%
5Y
N/A
All
-26.9%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PAROXETINE HCL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE HCL 40 MG TABLET, manufactured by NorthStar Rx LLC, is $0.1000 per EA (NDC 16714018403), effective Jul 29, 2026.
How has the price of PAROXETINE HCL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE HCL 40 MG TABLET has declined 26.9%. It has been tracked across 218 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for PAROXETINE HCL 40 MG TABLET?
Since Jun 1, 2022, the NADAC for PAROXETINE HCL 40 MG TABLET has ranged from a low of $0.0864 (Nov 20, 2024) to a high of $0.1459 (Aug 10, 2022), with a median of $0.1134 per EA.
Are there cheaper alternatives to PAROXETINE HCL 40 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PAROXETINE HCL 40 MG TABLET, is $0.0983 per EA — about 2% below PAROXETINE HCL 40 MG TABLET.
Who manufactures PAROXETINE HCL 40 MG TABLET?
PAROXETINE HCL 40 MG TABLET (NDC 16714018403) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.